Status:
COMPLETED
The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
MGH Multiple Sclerosis Clinic
University of Vermont
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic...
Detailed Description
This is a three year study which employed a step-wedge randomized design which exposed three of four participating centers to a healthcare QI intervention during the 3 year period. Each of the centers...
Eligibility Criteria
Inclusion
- Adults aged 18 years or older with documented clinically confirmed MS who are followed by one of the participating MS centers.
Exclusion
- Candidates will be excluded from study entry if they are unable or unwilling to provide informed consent.
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
694 Patients enrolled
Trial Details
Trial ID
NCT03480854
Start Date
July 1 2017
End Date
December 31 2020
Last Update
May 7 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurology Associates of Greater Orlando
Maitland, Florida, United States, 32751
2
Massachusetts General Hospital Multiple Sclerosis Center
Boston, Massachusetts, United States, 02114
3
Concord Hospital
Concord, New Hampshire, United States, 03301
4
University of Vermont Multiple Sclerosis Center
Burlington, Vermont, United States, 05401